Excessive salt intake significantly weakens an important arm of the immune system, scientists have shown.
Gardnerella bacteria in the cervicovaginal microbiome may serve as a biomarker to identify women infected with HPV who are at risk for progression to precancer.
A funding injection of up to $17 million could help cut the timeline for an effective vaccine for COVID-19 by six months.
Researchers have discovered distinct layers of astrocytes across the cerebral cortex that provide the strongest evidence to date of their specialisation across the brain.
Researchers have mapped immune responses from one of Australia's first COVID-19 patients, showing the body's ability to fight the virus and recover from the infection.
Maternal obesity increases the risk for obesity and metabolic perturbations in their offspring, but what are the mechanisms?
New checkpoint inhibitor treatments for cancer can activate tuberculosis in some patients — an infection that used to kill one in three people in the UK.
Microglia regulate the permeability of the brain's protective barrier in response to systemic inflammation — but the process can sometimes go wrong.
Researchers have uncovered differences between the male and female immune system that may explain why men are more susceptible to obesity and metabolism-related associated diseases.
US and UK scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus.
Fertility experts have shown that IVF success rates drop as men age, debunking the myth that only women experience declining fertility as they get older.
A recent study took a systematic approach to test the efficacy of 12 candidate probiotics strains from 10 species/subspecies of Bifidobacterium and Lactobacillus on stressed mice.
Fertility doctors have announced what is claimed to be the first baby to be born from an immature egg that was matured in the laboratory, frozen, then thawed and fertilised years later.
The newly discovered antimicrobials fall into a class of small antimicrobial proteins called bacteriocins, which represent versatile alternatives to some commonly used antibiotics.
The Democratic Republic of the Congo, Burundi, Ghana and Zambia have licensed an Ebola vaccine, just 90 days after its prequalification from the World Health Organization.